Table 4 Univariate analysis of biological parameters in relation to various clinical endpoints
| Â | End point | |||||||
|---|---|---|---|---|---|---|---|---|
| Â | Local control | Time to distant metastastis | Cause-specific survival | Overall survival | ||||
Parameter | χ 2 | P -value | χ 2 | P -value | χ 2 | P -value | χ 2 | P -value |
GLUT1 | 1.56 | 0.21 | 0.22 | 0.64 | 5.84 | 0.016 | 8.06 | 0.0045 |
CAIX | 0.82 | 0.36 | 0.29 | 0.59 | 4.16 | 0.041 | 8.57 | 0.0034 |
Ki-67 | 2.23 | 0.14 | 1.39 | 0.24 | 0.63 | 0.43 | 0.006 | 0.94 |
MVD | 0.068 | 0.79 | 0.011 | 0.92 | 0.002 | 0.96 | 0.07 | 0.79 |
Hot spot | 1.40 | 0.23 | 0.013 | 0.91 | 0.57 | 0.45 | 0.001 | 0.98 |
GLUT1=glucose transporter-1 protein; CAIX=carbonic anhydrase IX. Each parameter was categorised according to the median value; MVD=mean vascular density. | ||||||||